Advertisement

The Scientist

» Big Pharma and evolution

Most Recent

image: Home Cookin’

Home Cookin’

By | October 1, 2012

Laboratory-raised populations of dung beetles reveal a mother's extragenetic influence on the physiques of her sons.

2 Comments

image: Lamarck and the Missing Lnc

Lamarck and the Missing Lnc

By | October 1, 2012

Epigenetic changes accrued over an organism’s lifetime may leave a permanent heritable mark on the genome, through the help of long noncoding RNAs.

21 Comments

image: Evolving Dependence

Evolving Dependence

By | September 27, 2012

Scientists unravel the confusing molecular biology behind a fruit fly’s reliance on a single type of cactus.

1 Comment

image: Opinion: Eliminating Meningitis

Opinion: Eliminating Meningitis

By | September 17, 2012

Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.

1 Comment

image: Capsule Reviews

Capsule Reviews

By | September 1, 2012

Wired for Story, Dreamland, Homo Mysterious, and Vagina

0 Comments

image: Prayer Takes Precedence Over Science?

Prayer Takes Precedence Over Science?

By | August 14, 2012

A Bill of Rights amendment reaffirming the right to pray could have negative consequences for the teaching of evolution.

45 Comments

image: Gene Variation within a Tree

Gene Variation within a Tree

By | August 13, 2012

The root system of a tree species is genetically different than the leaves of that individual, potentially modifying scientists’ understanding of evolution.

8 Comments

image: Pharma's Fake Innovation Crisis?

Pharma's Fake Innovation Crisis?

By | August 13, 2012

Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.

2 Comments

image: New Human Species Discovered

New Human Species Discovered

By | August 9, 2012

Fossils from northern Kenya point to a new human species that lived in Africa nearly 2 million years ago.

0 Comments

image: Off-Label Drug Disclosure Inadequate

Off-Label Drug Disclosure Inadequate

By | August 7, 2012

Some 85 percent of researchers involved in promoting off-label drug use do not adequately disclose financial conflicts of interest in published articles.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
RayBiotech
RayBiotech

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
The Scientist
The Scientist
Life Technologies